Teva Pharmaceuticals (NYSE:TEVA) said today that it closed the $1.1 billion cash sale of its Paragard intrauterine copper contraceptive device to Cooper Cos.‘ (NYSE:COO) CooperSurgical unit. The deal included Teva’s manufacturing facility in Buffalo, N.Y., the pharma company reported. The move is part of Teva’s efforts to restructure its business, narrowing its focus on CNS and respiratory […]
Smiths Medical deals Wallace IVF biz to CooperSurgical for $174m
Smiths Group (LON:SMIN) said today it divested its Wallace in-vitro fertilization product line to Cooper Cos. (NYSE:COO) CooperSurgical subsidiary for $174 million (UK £140 million). The divestiture is part of an ongoing program at Smiths to focus its portfolio on “market leading positions of scale in its chosen markets,” the company said. The company said that proceeds from […]
A medtech veteran takes on C. diff from the gut
Most people don’t think much about Clostridium difficile, or C. diff., until it impacts their family. That was the case for Rebiotix CEO Lee Jones, who had never heard of the disease until her mother fell ill with it several years ago. Lee says she quickly learned how dangerous the disease really is – it’s responsible for more than 29,000 […]
CooperSurgical pays $47m for IVF screener Reprogenetics
Cooper Cos. (NYSE:COO) CooperSurgical subsidiary acquired in-vitro fertilization screening company Reprogenetics last week for nearly $47 million. Livingston, N.J.-based Reprogenetics offers pre-implantation genetic screening and diagnosis for in vitro fertilization, Cooper said. The $46.5 million deal isn’t expected to affect earnings per share this year or in 2016, but should be accretive thereafter, the company said. Reprogenetics put up […]
FDA warns CooperSurgical about Texas manufacturing plant
The FDA issued a warning to CooperSurgical (NSDQ:COO) after inspectors noted violations at the company’s Stafford, Texas, manufacturing facility.
MassDevice Network
@MassDevice
LinkedIn
Google+